Chinook Therapeutics Inc. Gains 58.32%
Mon, Jun 12, 2023 at 07:39 PM
Chinook Therapeutics Inc. (KDNY:NASDAQ) shot up at $37.98, a gain of 58.3%. On Mon, Jun 12, 2023, KDNY:NASDAQ hit a New 2-Week High of $37.98. The stock got featured on our News Catalysts scanner on Mon, Jun 12, 2023 at 04:22 PM in the 'BIOTECH' category. From Tue, May 30, 2023, the stock recorded 44.44% Up Days and 60.00% Green Days
About Chinook Therapeutics Inc. (KDNY:NASDAQ)
Chinook Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing precision medicines for kidney diseases.
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 5542.86%
- Auddia Inc. (AUUD:NASDAQ), 181.5%
- Asset Entities Inc. (ASST:NASDAQ), 75.65%
- Chinook Therapeutics Inc. (KDNY:NASDAQ), 58.32%
- Unico American Corporation (UNAM:NASDAQ), 55.68%
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 55.13%
- JIN MEDICAL INTERNATIONAL LTD. (ZJYL:NASDAQ), 54.75%
- Lottery.com Inc. (LTRY:NASDAQ), 51.57%
- Finch Therapeutics Group Inc. (FNCH:NASDAQ), 41.45%
- Accelerate Diagnostics, Inc. (AXDX:NASDAQ), 39.19%